Mucinous carcinoma of the breast
Mucinous carcinoma of the breast is a rare type of breast cancer characterized by the presence of mucin-producing cancer cells. This type of carcinoma is also known as colloid carcinoma. It accounts for approximately 2-3% of all breast cancer cases.
Pathophysiology[edit | edit source]
Mucinous carcinoma of the breast is distinguished by the production of mucin, a gelatinous substance, by the cancer cells. The mucin surrounds the cancer cells, forming clusters that can be identified under a microscope. This type of carcinoma typically has a slower growth rate compared to other forms of breast cancer and is often less aggressive.
Clinical Presentation[edit | edit source]
Patients with mucinous carcinoma of the breast may present with a palpable mass in the breast. The mass is usually well-defined and may feel soft or rubbery due to the mucin content. Other symptoms can include changes in the shape or size of the breast, skin dimpling, or nipple discharge.
Diagnosis[edit | edit source]
The diagnosis of mucinous carcinoma of the breast is typically made through a combination of mammography, ultrasound, and biopsy. Imaging studies may show a well-circumscribed mass, and a biopsy will reveal the characteristic mucin-producing cancer cells.
Treatment[edit | edit source]
Treatment options for mucinous carcinoma of the breast are similar to those for other types of breast cancer and may include surgery, radiation therapy, chemotherapy, and hormone therapy. The choice of treatment depends on the stage of the cancer, the patient's overall health, and other factors.
Prognosis[edit | edit source]
The prognosis for patients with mucinous carcinoma of the breast is generally favorable, especially when the cancer is detected early. This type of carcinoma tends to have a lower rate of metastasis and a higher survival rate compared to other forms of breast cancer.
Epidemiology[edit | edit source]
Mucinous carcinoma of the breast is more commonly diagnosed in older women, typically those over the age of 60. It is less common in younger women and men.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD